| Extracellular proteoglycans modify TGF-β bio-availability attenuating its signaling during skeletal muscle differentiation R Droguett, C Cabello-Verrugio, C Riquelme, E Brandan Matrix Biology 25 (6), 332-341, 2006 | 127 | 2006 |
| A novel modulatory mechanism of transforming growth factor-β signaling through decorin and LRP-1 C Cabello-Verrugio, E Brandan Journal of Biological Chemistry 282 (26), 18842-18850, 2007 | 125 | 2007 |
| Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation JC Casar, C Cabello-Verrugio, H Olguin, R Aldunate, NC Inestrosa, ... Journal of cell science 117 (1), 73-84, 2004 | 123 | 2004 |
| Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling MJ Acuña, P Pessina, H Olguin, D Cabrera, CP Vio, M Bader, ... Human molecular genetics 23 (5), 1237-1249, 2013 | 109 | 2013 |
| Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation C Vial, LM Zúñiga, C Cabello‐Verrugio, P Cañón, R Fadic, E Brandan Journal of cellular physiology 215 (2), 410-421, 2008 | 99 | 2008 |
| Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy MG Morales, J Gutierrez, C Cabello-Verrugio, D Cabrera, KE Lipson, ... Human molecular genetics 22 (24), 4938-4951, 2013 | 87 | 2013 |
| Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy E Brandan, C Cabello-Verrugio, C Vial Matrix Biology 27 (8), 700-708, 2008 | 86 | 2008 |
| CTGF/CCN‐2 over‐expression can directly induce features of skeletal muscle dystrophy MG Morales, C Cabello‐Verrugio, C Santander, D Cabrera, ... The Journal of pathology 225 (4), 490-501, 2011 | 80 | 2011 |
| Oxidative stress mediates the conversion of endothelial cells into myofibroblasts via a TGF-β1 and TGF-β2-dependent pathway I Montorfano, A Becerra, R Cerro, C Echeverría, E Sáez, MG Morales, ... Laboratory investigation 94 (10), 1068, 2014 | 78 | 2014 |
| Angiotensin II receptor type 1 blockade decreases CTGF/CCN2‐mediated damage and fibrosis in normal and dystrophic skeletal muscles C Cabello‐Verrugio, MG Morales, D Cabrera, CP Vio, E Brandan Journal of cellular and molecular medicine 16 (4), 752-764, 2012 | 68 | 2012 |
| Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells MG Morales, Y Vazquez, MJ Acuña, JC Rivera, F Simon, JD Salas, JÁ Ruf, ... The international journal of biochemistry & cell biology 44 (11), 1993-2002, 2012 | 67 | 2012 |
| Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth … MG Morales, D Cabrera, C Céspedes, CP Vio, Y Vazquez, E Brandan, ... Cell and tissue research 353 (1), 173-187, 2013 | 61 | 2013 |
| The low density lipoprotein receptor-related protein functions as an endocytic receptor for decorin E Brandan, C Retamal, C Cabello-Verrugio, MP Marzolo Journal of Biological Chemistry 281 (42), 31562-31571, 2006 | 59 | 2006 |
| The internal region leucine-rich repeat 6 of decorin interacts with low density lipoprotein receptor-related protein-1, modulates transforming growth factor (TGF)-β-dependent … C Cabello-Verrugio, C Santander, C Cofré, MJ Acuña, F Melo, E Brandan Journal of Biological Chemistry 287 (9), 6773-6787, 2012 | 56 | 2012 |
| Fibrotic response induced by angiotensin-II requires NAD (P) H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cells C Cabello-Verrugio, MJ Acuña, MG Morales, A Becerra, F Simon, ... Biochemical and biophysical research communications 410 (3), 665-670, 2011 | 54 | 2011 |
| Betaglycan Expression Is Transcriptionally Up-regulated during Skeletal Muscle Differentiation CLONING OF MURINE BETAGLYCAN GENE PROMOTER AND ITS MODULATION BY MyoD, RETINOIC … F López-Casillas, C Riquelme, Y Pérez-Kato, MV Ponce-Castañeda, ... Journal of Biological Chemistry 278 (1), 382-390, 2003 | 48 | 2003 |
| Nrf2 signaling and the slowed aging phenotype: evidence from long-lived models DR Bruns, JC Drake, LM Biela, FF Peelor, BF Miller, KL Hamilton Oxidative medicine and cellular longevity 2015, 2015 | 45 | 2015 |
| Lipopolysaccharide induces a fibrotic‐like phenotype in endothelial cells C Echeverría, I Montorfano, D Sarmiento, A Becerra, F Nuñez‐Villena, ... Journal of cellular and molecular medicine 17 (6), 800-814, 2013 | 45 | 2013 |
| Connective tissue growth factor induction by lysophosphatidic acid requires transactivation of transforming growth factor type β receptors and the JNK pathway C Cabello-Verrugio, G Córdova, C Vial, LM Zúñiga, E Brandan Cellular signalling 23 (2), 449-457, 2011 | 45 | 2011 |
| Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions L Pérez, N Muñoz-Durango, CA Riedel, C Echeverría, AM Kalergis, ... Cytokine & growth factor reviews 33, 41-54, 2017 | 44 | 2017 |